| All | Prophylactic Groups | p-Value* | Subgroups | p-Value* | ||
Amiodarone | Placebo | POAF | NO POAF | ||||
Variables |
|
|
|
|
|
|
|
Long term all-cause mortality (n (%)) | 71 (36) | 35 (37) | 36 (36) | 0.818 | 22 (49) | 49 (33) | 0.047* |
Readmission (n (%)) | 190 (97) | 91 (97) | 99 (98) | 0.674 | 44 (98) | 146 (97) | 1.000 |
Late AF (n (%)) | 34 (17) | 21 (22) | 13 (13) | 0.082 | 13 (29) | 21 (14) | 0.020* |
Stroke (n (%)) | 25 (13) | 12 (12) | 13 (14) | 0.684 | 9 (20) | 16 (11) | 0.100 |
Heart failure (n (%)) | 22 (11) | 12 (13) | 10 (10) | 0.527 | 5 (11) | 17 (11) | 0.967 |